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          Abstract 
  
A composite, exponential relaxation function, modulated by a periodic component, 
was used to fit to an experimental time series of blood glucose levels. The 11 
parameters function that allows for the detection of a possible rhythm transition was 
fitted to the experimental time series using a genetic algorithm. 
It has been found that the relaxation from a hyperglycemic condition following a 
change in the anti-diabetic treatment, can be characterized by a change from an initial 
12 hours’ ultradian rhythm to a near - 24 hours’ circadian rhythm.   
 
 
 
 
 
Introduction 
 
 
The present study describes, what appears to be a complex relaxation pattern of a 
hyperglycemic condition, upon change of treatment. 
The relaxation appears to follow an exponential envelope, modulated by periodic 
ultradian and circadian periodic rhythms.  
The apparent daily rhythmic pattern had been noticed from the very beginning of the 
blood glucose monitoring process, that had been initiated as the result of a 
unscheduled measurement of unusually high non-fasting glucose levels (maximal 
values approaching 300 mg/dL) detected, while the usual levels up to that point in 
time were about half that much, or less.  
It had been noticed that minima in glucose levels seem to cluster at early mornings (~ 
4-5 am) and afternoon (~ 4-5 pm), while maximum levels occur most frequently at 
around 10-11 am, and 9-11 pm, suggesting an apparent 12 hours rhythm (two maxima 
and two minima in 24 hours). As the relaxation to more moderate glucose levels had 
progressed, the rhythm had changed to near 24 hours circadian. 
It was this observation that motivated an analytical study using a long time 
exponential relaxation function modulated by a periodic function, with its amplitude 
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("swing") relaxing in an exponential manner as well. The suggested analytical 
function was then fitted onto the experimental glucose level data using a genetic 
algorithm procedure. This has enabled the determination of important relaxation 
parameters, such as the relaxation time constant, and the glucose level expected to be 
reached at long times. The 12 and near 24 hours rhythms were then established from 
fitting the analytic function as described below. 
Measurements were made using Ascensia ELITE XL blood glucose self test meter by 
a 59 years old DM type II, non insulin dependent diabetes (NIDD) patient. 
Diabetes was diagnosed about 9 years before this study took place, and since then it 
was treated with a small dose of oral Glibetic tablet (Glibenclamide, 2.5 mg daily). 
Both the fasting glucose and A1C (HbA1C) values, of 116 mg/dL, and 6.0 
respectively, last measured on July 2007, have been close, or within the norm, during 
all 9 years since the diagnosis of DM. 
The patient is also being treated for high BP, with moderate doses of ACE, Ca, and 
Alpha blockers. 
 
 
Methods 
 
 
Unusually high glucose level (275 mg/dL) was measured, by chance, on November 
18, 2007 at 22:00, and regular recording of glucose levels started since then, 3-5 times 
in 24 hours. From Nov 19 through to Nov 22, the intake of Glibetic was increased to 5 
mg daily, and a new antidiabetic tablet, Metformine 850 mg, was added. At first, 
Metformine was taken once a day, and after about two weeks, it was taken twice a 
day. This combination of oral antidiabetic medications was kept the same during the 
entire period of time analyzed here. 
It is important to note that glucose levels were measured at unequally spaced time 
points. One day measurements could have been taken in 6:30, 11:45, and 22:05 time 
sequence, while the next day, there might have been 7:20, 12:30, 21:20, 2:00 (of the 
next day) time points. On detection of extreme values, a repeated sampling was made 
after about an hour. At any case, glucose readings were always taken, at least 2 hours 
after meals. 
Data taken at unequal time intervals can’t be used directly as an input to Fourier 
spectral analysis, if the determination of a possible periodic rhythm is postulated to be 
embedded into the long time relaxation process. A prior interpolation to get “missing” 
data should be needed, which could introduce estimation errors in the power 
spectrum. 
Therefore, curve fitting algorithms were used, which do not require equally spaced 
time intervals. 
 
 
Curve fitting 
 
A simple approach, studied here, consists of using a large collection of unequally 
spaced data, spread over many sequent time blocks (days, in the present case), rather 
than using interpolated values, and trying to use Fourier spectral density methods.  
This approach can be regarded to belong to the curve fitting variety.  
A typical example of such curve fitting methods is the so called, "cosinor" [1] 
procedure for detecting circadian rhythms. For each pre-fixed period in the cosine 
 3 
function (starting from, say, 10 h, in 0.1 h increments, to about 25 h) it gives the 
weights of all the periodic components, and the  goodness of fit [2] of the most 
significant one. Dominant rhythms can thus be found.  
It is clearly a curve fitting method, using a simple trigonometric function to fit onto 
the data. The usual function form in this case needs just three parameters: the phase 
(called acrophase), the mean or level value (mesor), and the multiplicative constant, 
or amplitude, A.  
The cosinor method does not include any non-periodic functionality, such as an 
exponential relaxation envelope, and neither can it automatically find different 
dominant rhythms in different regions along the time series.  
These extra capabilities are possible with the genetic algorithm (GA) fitting method 
developed here. None of the fitting parameters (11 in total, including the time instant 
where rhythm transition can take place) are fixed in advance. GA is a global search 
algorithm that can find all these parameters, starting from random values. 
While the relaxation process studied here can be seen as dominated by the initial, 12 
hours rhythm, as shown below, the slower, overall rate dynamics of the exponential 
relaxation of the hyperglycemic condition on change of medications is most 
important. The long time relaxation dynamics is characterized by the time constant, 
and the long time limiting glucose level, given by the analytic fitting function. These 
two parameters give the important practical estimate as to how fast, and to what final 
glucose level could the medication initiated relaxation lead at the long run. 
To address these two important parameters, the first part, Y1(t) of the overall 
relaxation function that will be tried to fit the data, is a pure exponential relaxation 
function given as: 
 
 
Y1(t) = a + b*exp(-t/c)     eq. 1 
 
 
Here, at long times, t, the simulated glucose level, Y1(t), will approach, a, which is the 
long time, relaxed value of the Y function. At, t = 0, the function, Y1(t) = a + b, is the 
maximal, initial, value of the relaxation function.  
The important time constant, c, can be used for the estimation of the so called “half 
life time” (t1/2), which is the time expected for the Y to drop from its initial a + b  
value to a + (b/2), which is half way down, given by: 
 
 
½ = exp(-t1/2 / c)      or,       t1/2 = c*ln(2) = 0.693*c     eq. 2 
 
  
In the curve fitting result that leads to the 11.9 h and 24.2 h rhythms (see details 
below), the mean glucose level does fall halfway down at about ~0.7*544 = 380.8 
hours, or, in 380.8/24 = 15.9 days, which could be considered as a moderately fast 
response to the change in treatment. The expected, long time limiting glucose level, 
tends towards 98 mg/dL, as indicated by the value of a, meaning that of normal mean 
glucose levels can be expected on the long run. 
The periodic, modulation of the long time relaxation process is given by a second 
part, Y2(t), in the overall relaxation function. This part is combined with the main 
exponential relaxation Y1(t), and it has got its own exponential relaxation term, that 
determines the rate at which the amplitude of the periodic function relaxes with time.  
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The rhythmic part is given by: 
 
Y2(t) = (k + l*exp(-t/m))*cos(2*Pi((t/n) + p))  eq. 3 
 
Note the first exponential relaxation expression in the first parentheses, and the 
period, n, phase, p. 
The complete relaxation function is just, 
   
Y(t) = Y1(t) - Y2 (t)     eq. 4 
 
In this form, the pure exponential relaxation is modulated by the periodic part by 
simply subtracting it from the long time envelope of Y1(t). The GA then finds the best 
set of parameters defining both Y1 (t) and Y2 (t), so that their combination according 
to eq. 4, provides the best fitting to the experimental time series.  
After glucose monitoring progressed to longer times, it has been realized that the 
initial 12 hours rhythm in Y2 could be changing to longer period rhythms. To allow 
curve fitting for this possible rhythm transition, three additional parameters have been 
added to the 8 parameters being used so far. These three additional parameters are the 
following: 
 
tr – the point on the time axis, where rhythm changes, from its preceding one (that had 
been characterized by parameters, n, and, p, in eq. 3). 
mu – the parameter replacing, n, after passing time tr. 
ph – the parameter replacing, p, after passing time tr. 
 
There are now 11 adjustable parameters characterizing the two rhythms fitting 
function, Y(t). That was found as too many for a commercial curve fitting package – 
TBCurve (for DOS) which could handle only 8 parameters for user defined fitting 
functions. 
 
A simplified, 8 parameters fitting function (with a single rhythm) was then tried with 
the TBCurve software on the initial (in time) part of experimental data. A clear 
identification of the 12 hours period was found. 
Similarly, the dominant, 12 hours rhythm was clearly identified (p < 0.0001) using the 
cosinor method [2]. While cosinor procedure does show the longer period rhythms in 
the entire time series (that include 19.4 and 24.2 hours contributions), the transition 
point to a longer time rhythm at the last part of the time series can not be identified, 
and the overall, long time exponential relaxation can not be determined with cosinor, 
either. 
The genetic algorithm has been chosen to allow for a large number of parameters to 
be fitted to an analytic function simulating the experimental data, including relaxation 
and the location in time of the rhythm change, while avoiding local minima.    
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Genetic Algorithm and the cost function 
 
One of the search methods that can look for a global minimum or maximum, rather 
than falling into local extreemum points, is the genetic algorithm search that does not 
use seed values. Rather, it uses random values from the very beginning, and keeps 
"refreshing" the trial parameters population by what is known as the mutation 
operator, and forced randomization of relatively "fit" but "old" parameters sets (called 
"chromosomes" in genetic algorithms speak).    
This way, GA could find a global minimum in terms of the 11 parameters (in the 
present case) of the “cost” function. The cost function is defined as the mean 
“distance”, or difference, between experimental values of glucose at a given time 
points, and the corresponding values given by the fitting, analytic relaxation function, 
evaluated at the same time instants as the real data.  
The GA procedure used in this study can be described in a simplified way as: 
 
1. Initiation – create a population of a large number of 11 element groups (or, 
vectors/chromosomes). Each element is populated by a random number. 
2. Evaluation – evaluate the cost function (distance from experimental points) for 
each group of elements, which are the candidate parameters of the fitting 
function. The cost function in this case is the root mean square (RMS) value of 
the differences between the experimental and fitted points along the entire 
time series, as given by the fitting function, Y(t).  
3. Update the best chromosome (the leader) and protect it from the action of 
genetic operators that follow in the next step. Also update the parameters of all 
chromosomes that have been improved, meaning – decreased their cost 
function value relative to their state before the last genetic operation took 
place.  
Improved vectors that are not the leader (improved, but not reached the low 
cost function of the leader) will be protected from change, but only for a finite 
number of cycles. Any protected vector can donate the values of its elements 
in a possible crossover operation, but it keeps its original values (not 
“corrupted by inferiors") while still being protected. 
4. Do either a point to point crossover operation between randomly chosen pairs 
of chromosomes (exchanging one value, or more, of vector elements having 
the same index in vectors), or perform a complete randomization (mutation) of 
all vectors except the leader. Protected vectors (except of the leader) that 
haven’t improved any further, after a predetermined number of steps get their 
protection lifted, and can be changed by these genetic operations. This is what 
is known as "reheating". 
Vectors that did not improve, or got worse, are not protected against changing 
their elements. They are exposed to modification with a probability related to 
their decrease in fitness relative to the previous state. Like in simulated 
annealing (SA) algorithm, this probability is given by a Boltzmann 
exponential factor. The present method can therefore be classified as a 
genetic-annealing type of global search algorithms. 
5. Goto step No 2, and end cycles when reaching the predetermined number of 
cycles. 
 
The output of the GA is the elements of the leading vector. It is a group of 11 
parameters that gives the best fitting analytic function, Y(t), that have its values at 
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times, t, when the experimental data been measured, as close to the experimental 
glucose levels as the algorithm could get. 
 
 
 
 
Results and Discussion 
 
 
The raw data is given in Fig. 1 below. The short vertical lines at the lower edge of the 
figure denote 24 hours intervals on the time axis. 
 
Fig. 1 
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Two dominant curve fitting solutions have been obtained, based on the data available 
thus far. The first is – initial rhythm of 12 h, changing to 19.4 h, and the second – 
initial rhythm of 11.9 h changing to 24.2 h.  
The most recent set of fitting parameters, derived from the GA for 248 data points 
(spread over total time of 1626 hours) is as follows: 
 
For the 11.9 h / 24.2 h curve fitting result:  
a = 98, b = 64, c = 544 (the long time exponential relaxation envelope) 
k = 8, l = 69, m = 192, n = 11.9, p = 0.59 (exponentially relaxing periodic function)  
tr = 305.1, ph = 0.94, mu = 24.2 (rhythm transition location, new phase and period)  
 
For the 12 h / 19.4 h curve fitting result:  
a = 102, b = 70, c = 356 (the long time exponential relaxation envelope) 
k = 13, l = 71, m = 112, n = 12, p = 0.65 (exponentially relaxing periodic function)  
tr = 800.1, ph = 0.58, mu = 19.4 (rhythm transition location, new phase and period)  
 
Note that the units of the parameters are contextual to their meaning in the equations 
above. Thus, a, b, k, l are glucose concentration in mg/dL,  c, m, n, mu, tr are in hours, 
while p,  ph are pure numbers denoting the phases as fractions of 2Pi radians. 
These particular sets of parameters define an analytical function, Y(t), that when 
compared to real values of blood glucose at the experimental time points, produce a 
root mean square error (RMS) of  ~ 30 mg/dL. The analytical function is designed to 
 7 
deal with the dominant trends. The function is derived by minimizing the RMS – the 
cost function, between data and function. The rather low value of RMS (in 
comparison with several large, ~50-100 mg/dL swings found in data) suggests that a 
large portion of data points and the corresponding points on the function are in close 
proximity. 
 
That can be seen by inspecting Fig. 2 below (split into two non-overlapping parts, a 
and b, for clarity) which shows the individual experimental data points (circles on thin 
vertical lines) superimposed on the exponentially relaxing periodical 11.9 h / 24.2 h 
fitting function.  
 
 
Fig 2a 
0 100 200 300 400 500 600 700 800
50
100
150
200
250
300
Exponentially relaxing periodic function
Hours
G
lu
co
se
 
[m
g/
dL
]
 
 
The continuation of this time series: 
 
Fig 2b 
 
800 900 1000 1100 1200 1300 1400 1500 1600
50
100
150
200
250
300
Exponentially relaxing periodic function
Hours
G
lu
co
se
 
[m
g/
dL
]
 
 
 
 
 
 8 
The corresponding figures for the 12 h / 19.4 h curve fitting are in Fig 3 below.  
 
Fig 3a 
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The continuation of this time series: 
 
Fig 3b 
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Note the different time axis arrangement of the two parts of Fig 3a and 3b to clearly 
show the rhythm transition around 800 hours. 
Of a particular interest, one can notice the close correspondence between the location 
in time of the extreme points (of hypo, and hyperglycemic values) in data, and the 
function fitted. Thus, most hypo values (see for example the 291 mg/dL at 59 h data 
point) coincide in time with a sinus maximum of the periodic fitting function, Y(t). 
The correspondence is most evident in the initial 11.9 hours rhythm region, up to the 
point of 305 hours on the time axis (for the 11.9 h / 24.2 h fitting, in Fig. 2) , where 
the transition to the longer, circadian-like rhythm, takes place. Similarly, the clear 
correspondence can be noticed in the initial 12 h rhythm region, up to the 800 h point 
in time, for the 12 h / 19.4 h curve fitting, shown in Fig. 3. 
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The most significant parameters are found in the following categories: 
 1. The long time limit of the relaxation envelope, a = 98 - 102 mg/dL, which can 
suggest that the medical treatment response can be expected to lead to an acceptable 
result. 
2.  Time constant of the long time relaxation envelope is, 544 hours, for the 11.9 h / 
24.2 h fitting function. The half life time is then, ~0.7*544 = 380.8 hours or, 380.8/24 
= 15.9 days. It means that the initial high mean levels of glucose dropped to half their 
value in 15.9 days, which shows that the treatment became effective in a reasonable 
time. 
3. The location (parameter, tr) on the time axis of the change in rhythm from 12 hours 
(parameter, n) to ~20, or ~24 hours. This has both practical and theoretical value.  
Thus, the treatment at the initial stage might benefit from a tighter and more frequent 
scheduling of medications intake, based on the location in time of the extreme values 
of glucose levels. 
The rhythm’s transition itself can be discussed in the context of non-linear dynamic 
systems where periodic trajectories can undergo what is known as period doubling 
under imposed change of control parameters, and even leading to chaotic 
characteristics under extreme values of such parameters. The relaxation to the more 
common circadian rhythm upon the relaxation of the initial state of hyperglycemia, 
can suggest the transition from period doubling back to the normal state, or close to it. 
One of main criticisms of the present study can be the fact that the raw data used is 
not compensated for times of meals, physical effort, rest, and some other important 
factors.  
While glucose was always sampled 2-4 hours after meals, or in the morning, after 
fasting, the ideal case would be a constant food intake, for example. However, the fact 
that measured glucose values were almost always higher at about 7-8 AM (just before 
breakfast), than those measured about two-three hours before that, can suggest that 
given a regular pattern of meals, the glucose levels at some time points are less 
dependent on meals than other time points. The same can be noted on the relatively 
high glucose levels at around 10-11 PM, which is quite distant from the dinner, 
usually taken at around 6-7 PM.  
It is important to note that glucose measurements were taken at a large spread of 
times. The very high statistical significance of the initial, 12 hours rhythm, 
p < 0.0001, can indicate that this result is indeed significant, given the wide spread of 
measurement times. 
The circadian 24 h rhythm is known to exist in non-diabetics [3]. One of its 
expressions is the temporary rise in glucose levels in the evening. The term “afternoon 
diabetes” was coined to describe this phenomenon because of the increased potential 
of a false-positive diagnosis of diabetes in the afternoon, as compared with the 
morning. This “afternoon diabetes” was shown to be a true effect of the time in the 
day, independent of fasting details [3]. This phenomenon of the true effect of the time 
is similar to the consistently higher levels of glucose measured at around 8 AM, 
relative to those at 5 AM, and high levels at 10 PM, as observed with the 12 h 
rhythms described above. 
 The important question as to why the best fit in the present study indicates an 
approach to a circadian rhythm, with a 19.4 h or 24.2 periods (the two dominant curve 
fitting solutions) rather than to expected 24 h period is a subject for a further study. At 
the present time, it can be noted that apparently the non-harmonic, 19.4 h rhythm 
(unlike the 12 h rhythm) can suggest a possible non-stationary effect of a non 
completed process of relaxation to the circadian, 24 h rhythm.    
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